Tissue-engineered composite tracheal grafts create mechanically stable and biocompatible airway replacements

J Tissue Eng. 2022 Jun 26:13:20417314221108791. doi: 10.1177/20417314221108791. eCollection 2022 Jan-Dec.

Abstract

We tested composite tracheal grafts (CTG) composed of a partially decellularized tracheal graft (PDTG) combined with a 3-dimensional (3D)-printed airway splint for use in long-segment airway reconstruction. CTG is designed to recapitulate the 3D extracellular matrix of the trachea with stable mechanical properties imparted from the extraluminal airway splint. We performed segmental orthotopic tracheal replacement in a mouse microsurgical model. MicroCT was used to measure graft patency. Tracheal neotissue formation was quantified histologically. Airflow dynamic properties were analyzed using computational fluid dynamics. We found that CTG are easily implanted and did not result in vascular erosion, tracheal injury, or inflammation. Graft epithelialization and endothelialization were comparable with CTG to control. Tracheal collapse was absent with CTG. Composite tracheal scaffolds combine biocompatible synthetic support with PDTG, supporting the regeneration of host epithelium while maintaining graft structure.

Keywords: 3D-printed splint; Composite tracheal graft; partially decellularized tracheal scaffold; tissue regeneration; tracheal collapse.